VCYT
$27.95
Revenue | $114.47Mn |
Net Profits | $7.05Mn |
Net Profit Margins | 6.16% |
PE Ratio | 65.5 |
Veracyte, Inc.’s revenue jumped 18.2% since last year same period to $114.47Mn in the Q1 2025. On a quarterly growth basis, Veracyte, Inc. has generated -3.51% fall in its revenue since last 3-months.
Veracyte, Inc.’s net profit jumped 478.06% since last year same period to $7.05Mn in the Q1 2025. On a quarterly growth basis, Veracyte, Inc. has generated 37.83% jump in its net profits since last 3-months.
Veracyte, Inc.’s net profit margin jumped 419.84% since last year same period to 6.16% in the Q1 2025. On a quarterly growth basis, Veracyte, Inc. has generated 42.83% jump in its net profit margins since last 3-months.
Veracyte, Inc.’s price-to-earnings ratio after this Q1 2025 earnings stands at 65.5.
EPS Estimate Current Quarter | 0.11 |
EPS Estimate Current Year | 0.11 |
Veracyte, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.11 - a 162.18% jump from last quarter’s estimates.
Veracyte, Inc.’s earning per share (EPS) estimates for the current year stand at 0.11.
Earning Per Share (EPS) | 0 |
Veracyte, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q2 2025. This indicates that the Veracyte, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-05-08 | -0.17 | 0.31 | 282.35% |
2025-07-30 | 0.11 | 0 | -100% |